Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
404 participants
INTERVENTIONAL
2018-05-04
2022-05-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study was of epidemiological type, comparative before-elsewhere. The difficulty of controlling for confounders in this type of study limits the scope of these conclusions. The efficacy hypothesis of PRADO IC is therefore always posed in the French context
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Research Into Factors Determining Participation in 2 Interventions Modifying the Care Pathways of Patients With Heart Failure: PRADO and Telemedicine
NCT05417490
Optimized Medico-pharmaceutical Collaboration in the Drug Management of Patients With Heart Failure
NCT03902028
Outcomes of Patients With Heart Failure Hospitalized in an Internal Medicine Unit
NCT04845126
Optimizing Treatments for Heart Failure During Hospitalization
NCT05910437
Readmission Risk of Patients With Heart Failure.
NCT04984928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRADO-IC
PRADO-IC
1. Help of administrative employees to schedule the first medical visits after an hospitalization for heart failure.
2. Home nurse's visiting program, during 2 to 6 months after the hospitalization for heart failure.
Usual care
No intervervention Usual Care
Advices about the care pathway, provided by care givers. Prescription of home nurse's visits if needed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PRADO-IC
1. Help of administrative employees to schedule the first medical visits after an hospitalization for heart failure.
2. Home nurse's visiting program, during 2 to 6 months after the hospitalization for heart failure.
No intervervention Usual Care
Advices about the care pathway, provided by care givers. Prescription of home nurse's visits if needed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalization for heart failure
* Subject living at home
* Informed consent
Exclusion Criteria
* subject without health insurance
* terminal kidney failure
* programmed heart surgery
* waiting for heart transplantation
* psycho-cognitive impairment
* patient not autonomous for mobility at home
* supportive care
* planned move to medical home for elderly people in the coming 6 months
* no fluent french
* not able to provide informed consent
* participating to other study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Roubille F, Labarre JP, Georger F, Galinier M, Herman F, Berdague P, Nogue E, Petroni T, Delbaere Q, Malak A, Robin M, Prunet E, Leclercq F, Pasquie JL, Papinaud L, Mercier G, Ricci JE, Cayla G, Duflos C. PRADOC: A Multicenter Randomized Controlled Trial to Assess the Efficiency of PRADO-IC, a Nationwide Pragmatic Transition Care Management Plan for Hospitalized Patients With Heart Failure in France. J Am Heart Assoc. 2024 Aug 6;13(15):e032931. doi: 10.1161/JAHA.123.032931. Epub 2024 Jul 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A01732-51
Identifier Type: REGISTRY
Identifier Source: secondary_id
RECHMPL17_0113
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.